Table Of Contents

1. Market Context & Strategic Relevance

1.1 Opening Context (Why the market matters)

1.1.1 Why This Market Is Gaining Strategic Attention

1.1.2 Business Decisions This Report Supports

1.2 Scope

1.3 Research & Methodology

2. Executive Summary

2.1 Market Snapshot

2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

2.3 Market Size & Forecast, By Segmentation, 2022–2035

2.3.1 Market Size By Testing Type

2.3.2 Market Size By Product

2.3.3 Market Size By Application

2.3.4 Market Size By End User

2.4 Market Share & Bps Analysis By Region, 2025

2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

2.6 Industry CxO’s Perspective

3. Market Overview

3.1 Market Dynamics

3.1.1 Drivers

3.1.2 Restraints

3.1.3 Opportunities

3.1.4 Key Market Trends

3.2 Industry PESTLE Analysis

3.3 Key Industry Forces (Porter’s) Impacting Market Growth

3.4 Industry Supply Chain Analysis

3.4.1 Instruments, Reagents & Consumable Suppliers

3.4.2 Toxicology Testing Service & Software Providers

3.4.3 Contract Research Organizations & Laboratories

3.4.4 Pharmaceutical, Biotechnology & Academic End Users

3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 Toxicology Testing Volume & Throughput Metrics

4.1.1 Global Toxicology Drug Screening Test Volumes

4.1.2 Average Number of Compounds Screened per Study

4.1.3 In Vitro, In Vivo and In Silico Testing Mix Ratios

4.1.4 Laboratory Turnaround Time and Throughput Benchmarks

4.2 Assay Performance & Safety Outcome Statistics

4.2.1 Compound Attrition and Toxicity Failure Rates

4.2.2 Assay Sensitivity, Specificity and Predictive Accuracy Benchmarks

4.2.3 False Positive and False Negative Rate Metrics

4.2.4 Concordance Between In Vitro, In Vivo and Clinical Outcomes

4.3 Instrument, Reagent & Operating Economics

4.3.1 Installed Base of Toxicology Screening Instruments

4.3.2 Instrument Utilization and Testing Capacity Metrics

4.3.3 Reagent and Consumable Consumption per Assay

4.3.4 Average Cost per Test and Cost per Compound Screened

4.4 Laboratory Workflow & Service Metrics

4.4.1 In-House vs. Outsourced Toxicology Testing Penetration

4.4.2 Automated vs. Manual Workflow Adoption Rates

4.4.3 Sample-to-Result Turnaround Benchmarks

4.4.4 Repeat Testing and Service Order Metrics

4.5 Technology, Quality & Innovation Indicators

4.5.1 Organ-on-Chip and 3D Cell Model Adoption Statistics

4.5.2 In Silico Predictive Toxicology Model Validation Benchmarks

4.5.3 Regulatory Guideline Compliance and GLP Certification Rates

4.5.4 Product Launches, Patent Filings and Technology Development Activity

5. Toxicology Drug Screening Market Segmental Analysis & Forecast, By Testing Type, 2022–2035, Value (USD Billion)

5.1 Introduction

5.2 In Vitro

5.2.1 Key Trends

5.2.2 Market Size & Forecast, 2022 – 2035

5.3 In Vivo

5.4 In Silico

6. Toxicology Drug Screening Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

6.1 Introduction

6.2 Instruments

6.2.1 Key Trends

6.2.2 Market Size & Forecast, 2022–2035

6.3 Reagents & Consumables

6.4 Animal Models

6.5 Software

6.6 Other Products

7. Toxicology Drug Screening Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

7.1 Introduction

7.2 Immunotoxicity

7.2.1 Key Trends

7.2.2 Market Size & Forecast, 2022–2035

7.3 Systemic Toxicity

7.4 Developmental & Reproductive Toxicity (DART)

7.5 Endocrine Disruption

7.6 Other Applications

8. Toxicology Drug Screening Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 Pharmaceutical & Biotechnology Companies

8.2.1 Key Trends

8.2.2 Market Size & Forecast, 2022–2035

8.3 Contract Research Organizations

8.4 Academic & Research Institutes

9. Toxicology Drug Screening Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

9.2.1 Key Trends

9.2.2 Toxicology Drug Screening Market Size & Forecast, By Testing Type, 2022–2035

9.2.3 Toxicology Drug Screening Market Size & Forecast, By Product, 2022–2035

9.2.4 Toxicology Drug Screening Market Size & Forecast, By Application, 2022–2035

9.2.5 Toxicology Drug Screening Market Size & Forecast, By End User, 2022–2035

9.2.6 Toxicology Drug Screening Market Size & Forecast, By Country, 2022–2035

9.2.6.1 USA

9.2.6.2 Canada

9.3 Europe

9.3.1 Key Trends

9.3.2 Toxicology Drug Screening Market Size & Forecast, By Testing Type, 2022–2035

9.3.3 Toxicology Drug Screening Market Size & Forecast, By Product, 2022–2035

9.3.4 Toxicology Drug Screening Market Size & Forecast, By Application, 2022–2035

9.3.5 Toxicology Drug Screening Market Size & Forecast, By End User, 2022–2035

9.3.6 Toxicology Drug Screening Market Size & Forecast, By Country, 2022–2035

9.3.6.1 Germany

9.3.6.2 UK

9.3.6.3 France

9.3.6.4 Italy

9.3.6.5 Spain

9.3.6.6 Russia

9.3.6.7 Poland

9.3.6.8 Rest of Europe

9.4 Asia-Pacific

9.4.1 Key Trends

9.4.2 Toxicology Drug Screening Market Size & Forecast, By Testing Type, 2022–2035

9.4.3 Toxicology Drug Screening Market Size & Forecast, By Product, 2022–2035

9.4.4 Toxicology Drug Screening Market Size & Forecast, By Application, 2022–2035

9.4.5 Toxicology Drug Screening Market Size & Forecast, By End User, 2022–2035

9.4.6 Toxicology Drug Screening Market Size & Forecast, By Country, 2022–2035

9.4.6.1 China

9.4.6.2 India

9.4.6.3 Japan

9.4.6.4 South Korea

9.4.6.5 Australia

9.4.6.6 ASEAN Countries

9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

9.5.1 Key Trends

9.5.2 Toxicology Drug Screening Market Size & Forecast, By Testing Type, 2022–2035

9.5.3 Toxicology Drug Screening Market Size & Forecast, By Product, 2022–2035

9.5.4 Toxicology Drug Screening Market Size & Forecast, By Application, 2022–2035

9.5.5 Toxicology Drug Screening Market Size & Forecast, By End User, 2022–2035

9.5.6 Toxicology Drug Screening Market Size & Forecast, By Country, 2022–2035

9.5.6.1 Brazil

9.5.6.2 Mexico

9.5.6.3 Argentina

9.5.6.4 Rest of Latin America

9.6 Middle East & Africa

9.6.1 Key Trends

9.6.2 Toxicology Drug Screening Market Size & Forecast, By Testing Type, 2022–2035

9.6.3 Toxicology Drug Screening Market Size & Forecast, By Product, 2022–2035

9.6.4 Toxicology Drug Screening Market Size & Forecast, By Application, 2022–2035

9.6.5 Toxicology Drug Screening Market Size & Forecast, By End User, 2022–2035

9.6.6 Toxicology Drug Screening Market Size & Forecast, By Country, 2022–2035

9.6.6.1 Saudi Arabia

9.6.6.2 South Africa

9.6.6.3 Rest of Middle East & Africa

10. Competitive Landscape

10.1 Key Players' Positioning

10.2 Competitive Developments

10.2.1 Year-Wise Strategies & Development, 2022–2026

10.3 Market Share Analysis, 2025

10.4 Product/Service & Application Benchmarking

10.4.1 Product/Service Specifications & Features By Key Players

10.4.2 Product/Service Heatmap By Key Players

10.4.3 Application Heatmap By Key Players

10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

10.6.1 Agilent Technologies, Inc.

10.6.1.1 Company Overview & Snapshot

10.6.1.2 Product/Service Portfolio

10.6.1.3 Key Company Financials

10.6.1.4 Geographical Presence

10.6.1.5 SWOT Analysis

10.6.2 Bio-Rad Laboratories, Inc.

10.6.3 Merck KGaA

10.6.4 Charles River Laboratories International, Inc.

10.6.5 Eurofins Scientific SE

10.6.6 Danaher Corporation

10.6.7 Labcorp Holdings Inc.

10.6.8 Promega Corporation

10.6.9 Thermo Fisher Scientific Inc.

10.6.10 WuXi AppTec Co., Ltd.

10.6.11 Inotiv, Inc.

10.6.12 Instem plc

10.6.13 Emulate, Inc.

10.6.14 CN Bio Innovations Ltd.

10.6.15 MIMETAS B.V.

10.6.16 InSphero AG

10.6.17 Certara, Inc.

10.6.18 Simulations Plus, Inc.

10.6.19 SGS SA

11. Analyst Recommendations

11.1 SNS Insider Opportunity Map

11.2 Industry Low-Hanging Fruit Assessment

11.3 Market Entry & Growth Strategy

11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

14.1 List Of Tables

14.2 List Of Figures